Literature DB >> 32283283

Positive effects of COVID-19 control measures on influenza prevention.

Di Wu1, Jianyun Lu2, Yanhui Liu3, Zhoubin Zhang4, Lei Luo5.   

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become a pandemic threat to the whole world. At the same time, influenza virus has been active, with influenza virus and SARS-CoV-2 sharing the same transmission routes. This article aims to alert clinicians of the presence of co-infection with these two viruses and to describe the effect of the measures taken to fight COVID-19 on influenza prevention and control.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  COVID-19; Control; Influenza; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32283283      PMCID: PMC7151395          DOI: 10.1016/j.ijid.2020.04.009

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


The coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has now become a worldwide disaster (Wu and McGoogan, 2020). According to the World Health Organization (WHO) (WHO, 2020a), as of March 31, 2020, more than 750 890 cases had been confirmed, including 36 405 deaths. COVID-19 is an infectious respiratory disease that shares the same routes and means of transmission as influenza. A relatively high level of reported influenza cases and influenza-like illness (ILI) has been observed in China over the last year, with the same trend reported in the United States and by the WHO (WHO, 2020b). Wu et al. (Wu et al., 2020) have reported the case of a patient co-infected with SARS-CoV-2 and influenza A virus. Also, Li and Wang (Li and Wang, 2020) have reported the need to be alert to the superposed effect of seasonal influenza while fighting pneumonia caused by the novel coronavirus. According to the Chinese National Influenza Center, ILI activity (ILI%) in 2020 in South China was lower than that in North China from week 5 to week 10, and this situation reversed in the subsequent 2 weeks; in contrast, in 2019, ILI% was constantly higher in South China than in North China for the first 11 weeks (except for the first week of 2019) (Figure 1 A). Overall, ILI% in 2020 across the whole of China has been higher than that observed in 2019, and the same trend has been observed in the positive rate of specimens (Figure 1B).
Figure 1

Positive effects of COVID-19 control measures on influenza prevention.

(A) The influenza-like illness (ILI) of the first 10 weeks of the year, China. (B) the positive rate of the specimens of the first 10 weeks of the year, China. (C) The influenza-like illness (ILI) of the first 10 weeks of Guangzhou City. (D) The positive rate of the specimens of the first 10 weeks of the year, Guangzhou City. (E) The reported cases of COVID-19 in Guangzhou City. (F) The reported cases of influenza in Guangzhou City.

Positive effects of COVID-19 control measures on influenza prevention. (A) The influenza-like illness (ILI) of the first 10 weeks of the year, China. (B) the positive rate of the specimens of the first 10 weeks of the year, China. (C) The influenza-like illness (ILI) of the first 10 weeks of Guangzhou City. (D) The positive rate of the specimens of the first 10 weeks of the year, Guangzhou City. (E) The reported cases of COVID-19 in Guangzhou City. (F) The reported cases of influenza in Guangzhou City. Guangzhou City, in South China, has also seen a relatively higher ILI% over the last 7 weeks of 2020 when compared to 2019 (Figure 1C), and the overall positive rate of specimens has been lower in 2020 when compared to 2019 (Figure 1D). However, reported cases of COVID-19 in Guangzhou City decreased continuously from week 6 to week 11 of 2020, when the local transmission of COVID-19 then ceased in Guangzhou City. There has since been a dramatic increase in cases; all of these have been reported to be imported cases (Figure 1E). At the same time, the number of reported influenza cases showed a decreasing trend from the beginning of 2020, while there were two growth waves in 2019 during the same period (Figure 1F). We performed an analysis and found that the measures taken by the Chinese government to control SARS-CoV-2 also controlled the transmission of influenza virus, since these two viruses share the same routes and means of transmission: (1) nucleic acid testing was performed on all suspected patients, so the patients infected with influenza were also identified; (2) people were quarantined, therefore limiting the possibility of transmission of the infection to others; (3) social lockdown at the earliest onset of the outbreak meant that the possibility of transmission was even smaller; (4) the whole population were wearing facemasks, better protecting themselves from the infection; (5) there was extensive screening for fever cases, thereby reducing infection sources; (6) screening of close contacts of confirmed cases and suspected cases was performed, further reducing the number of infection sources. Thus, there would be a positive effect on influenza prevention and control, as well as on other infectious respiratory diseases, which may also have been prevented to some extent while fighting the pandemic of COVID-19.

Author contributions

Di Wu, Jianyun Lu, and Lei Luo designed the study and drafted the manuscript; Yanhui Liu collected and analyzed the data; Zhoubin Zhang and Lei Luo revised the manuscript. All authors read and approved the final manuscript.

Funding

This work was supported by grants from the (81803325), the Medical Science and Technology Project of Guangzhou (20191A011064, 20201A011067), and the Guangdong Medical Science and Technology Research Project (A2019379).

Conflict of interest

None declared.
  2 in total

1.  Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.

Authors:  Xiaojing Wu; Ying Cai; Xu Huang; Xin Yu; Li Zhao; Fan Wang; Quanguo Li; Sichao Gu; Teng Xu; Yongjun Li; Binghuai Lu; Qingyuan Zhan
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

2.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  2 in total
  35 in total

1.  Influenza-associated severe acute respiratory infections among children under five years old in Morocco, September 2017 to March 2019.

Authors:  Zakia Regragui; Abderrahman Bimouhen; Fatima El Falaki; Hassan Ihazmad; Samira Benkerroum; Soumia Triki; Imad Cherkaoui; Chafiq Mahraoui; Abdelkarim Filali-Maltouf; Leila Medraoui; Hicham Oumzil
Journal:  Infez Med       Date:  2022-09-01

2.  Changes in Temporal Properties of Notifiable Infectious Disease Epidemics in China During the COVID-19 Pandemic: Population-Based Surveillance Study.

Authors:  Xixi Zhao; Meijia Li; Naem Haihambo; Jianhua Jin; Yimeng Zeng; Jinyi Qiu; Mingrou Guo; Yuyao Zhu; Zhirui Li; Jiaxin Liu; Jiayi Teng; Sixiao Li; Ya-Nan Zhao; Yanxiang Cao; Xuemei Wang; Yaqiong Li; Michel Gao; Xiaoyang Feng; Chuanliang Han
Journal:  JMIR Public Health Surveill       Date:  2022-06-23

3.  Prioritizing Infection Prevention and Control Activities for SARS-CoV-2 (COVID-19): A Multi-Criteria Decision-Analysis Method.

Authors:  Adnan Sarwar; Muhammad Imran
Journal:  J Healthc Leadersh       Date:  2021-02-26

4.  Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada.

Authors:  Philippe Lagacé-Wiens; Claire Sevenhuysen; Liza Lee; Andrea Nwosu; Tiffany Smith
Journal:  Can Commun Dis Rep       Date:  2021-03-31

5.  Delayed season's onset and reduction of incidence of bronchiolitis during COVID-19 pandemic.

Authors:  Sergio Ghirardo; Nicola Ullmann; Marta L Ciofi Degli Atti; Massimiliano Raponi; Renato Cutrera
Journal:  Pediatr Pulmonol       Date:  2021-05-18

6.  A data driven epidemic model to analyse the lockdown effect and predict the course of COVID-19 progress in India.

Authors:  Bijay Kumar Sahoo; Balvinder Kaur Sapra
Journal:  Chaos Solitons Fractals       Date:  2020-06-20       Impact factor: 9.922

Review 7.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

Review 8.  Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?

Authors:  Jess Pedrina; John Stambas
Journal:  Front Mol Biosci       Date:  2021-07-05

9.  What to expect for the influenza season 2020/21 with the ongoing COVID-19 pandemic in the World Health Organization European Region.

Authors:  Cornelia Adlhoch; Richard Pebody
Journal:  Euro Surveill       Date:  2020-10

Review 10.  Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.

Authors:  Hossein Khorramdelazad; Mohammad Hossein Kazemi; Alireza Najafi; Maryam Keykhaee; Reza Zolfaghari Emameh; Reza Falak
Journal:  Microb Pathog       Date:  2020-11-03       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.